Related Experiment Video

Updated: May 21, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

Non-pharmacological therapy for atrial fibrillation: managing the left atrial appendage

Sushil Allen Luis1, Damian Roper, Alexander Incani

  • 1Department of Cardiology, The Prince Charles Hospital, Rode Road, Chermside, QLD 4032, Australia.

Cardiology Research and Practice
|June 6, 2012
PubMed

Insights

Atrial fibrillation (AF) increases stroke risk, particularly due to the left atrial appendage (LAA). Excising the LAA is a promising strategy to reduce stroke incidence, with modern techniques now available.

Area of Science:

  • Cardiology
  • Vascular Surgery
  • Geriatric Medicine

Background:

  • Increasing prevalence of atrial fibrillation (AF) in aging populations contributes to significant morbidity and mortality.
  • AF is a major risk factor for ischemic stroke, accounting for up to 20% of cases.
  • The left atrial appendage (LAA) is a key contributor to stroke risk in AF due to altered hemodynamics promoting thrombus formation.

Purpose of the Study:

  • To review the historical hypothesis and recent advancements in left atrial appendage (LAA) exclusion for stroke risk reduction in atrial fibrillation (AF).
  • To discuss the current viable surgical and percutaneous techniques for LAA exclusion.

Main Methods:

  • Literature review of studies on atrial fibrillation, stroke, and left atrial appendage interventions.
  • Analysis of the pathophysiological mechanisms linking LAA to thrombus formation in AF.
  • Overview of established and emerging surgical and percutaneous LAA exclusion techniques.

Main Results:

  • The LAA's role in thrombus formation within the context of AF is well-established.
  • Recent technological and procedural advancements enable safe and effective LAA exclusion.
  • Both surgical and percutaneous approaches offer viable options for LAA exclusion.

Conclusions:

  • Left atrial appendage exclusion is a recognized strategy to mitigate stroke risk in patients with atrial fibrillation.
  • The development of safe and effective surgical and percutaneous techniques has made LAA exclusion a practical clinical option.
  • Further research and clinical application of LAA exclusion techniques are warranted to optimize patient outcomes.

More Related Videos

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation08:10

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation

Published on: July 20, 2022

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...